Geron (GERN) Accumulated Depreciation (2011 - 2024)
Geron's (GERN) quarterly Accumulated Depreciation came in at $1.7 million in Q4 2024, up 37.86% year-on-year from $1.2 million in Q1 2024, and up 37.86% quarter-over-quarter from $1.2 million in Q4 2023.
Geron (GERN) Accumulated Depreciation (2011 - 2024) Analysis & Trends
Geron has disclosed Accumulated Depreciation across 14 years of filings, most recently posting $1.7 million for Q4 2024.
- Accumulated Depreciation for Q4 2024 came in at $1.7 million, up 37.86% year-over-year; the trailing twelve-month figure through Dec 2024 was $1.7 million (up 37.86% YoY), and the FY2024 annual result was $1.7 million, up 37.86% from the prior year.
- Accumulated Depreciation came in at $1.7 million for Q4 2024 at Geron, up from $1.2 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $1.7 million in Q4 2024 to a low of $613000.0 in Q4 2020.
- The 5-year median for Accumulated Depreciation is $896000.0 (2022), against an average of $1.0 million.
- Across the five-year window, Accumulated Depreciation decreased 27.28% in 2020 and soared 37.86% in 2024, its largest moves.
- Geron's Accumulated Depreciation stood at $613000.0 in 2020, then increased by 6.04% to $650000.0 in 2021, then jumped by 37.85% to $896000.0 in 2022, then soared by 37.39% to $1.2 million in 2023, then soared by 37.86% to $1.7 million in 2024.
- The last three Accumulated Depreciation figures came in at $1.7 million (Q4 2024), $1.2 million (Q4 2023), and $896000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 896,000.00 |
| Dec 31, 2021 | 650,000.00 |
| Dec 31, 2020 | 613,000.00 |
| Dec 31, 2019 | 843,000.00 |
| Dec 31, 2018 | 779,000.00 |
| Dec 31, 2017 | 720,000.00 |
| Dec 31, 2016 | 1.21 Mn |
| Dec 31, 2015 | 1.25 Mn |
| Dec 31, 2014 | 1.19 Mn |
| Dec 31, 2013 | 1.19 Mn |
| Dec 31, 2012 | 12.48 Mn |
| Dec 31, 2011 | 17.30 Mn |